Cue Biopharma, Inc. (CUE)
Market Closed
1 Sep, 20:00
$
28. 44
+2.92
+11.442%
After Hours
$
+1.03 +3.6217% 29. 47
67.06M Market Cap
- P/E Ratio
- Div Yield
177,266 Volume
- Eps
$ 25.52
Previous Close Investors:
Want to track CUE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cue Biopharma, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Didric Cederholm Lion Point Capital LP | 52,928 | $1.35M | $1.81M | $458,356.48 | 33.91% |
 Richard Slavik Newbridge Financial Services Group Inc. | 99 | $2,528.46 | $3,385.8 | $857.34 | 33.91% |
 Tyler Glazier New Millennium Group LLC | 189.75 | $1,753.67 | $5,092.89 | $3,339.22 | 190.41% |
 Edward Lowndes Angeles Wealth Management LLC | 7,000 | $178,780 | $187,880 | $9,100 | 5.09% |
 Leonid Berline ARMSTRONG ADVISORY GROUP Inc. | 3.96 | $342 | $106.29 | -$235.71 | -68.92% |
 Kevin Roan Stempoint Capita LLP | 66,995 | $1.71M | $2.29M | $580,176.7 | 33.91% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 1 | $25.54 | $26.6 | $1.06 | 4.15% |
 Joshua Stipcich Tidemark, LLC | 50 | $357.78 | $1,356 | $998.22 | 279% |
 Zachary Canonico DIADEMA PARTNERS LP | 48,369 | $1.24M | $1.65M | $418,875.54 | 33.91% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 12,332 | $314,959.28 | $334,443.84 | $19,484.56 | 6.19% |
